Clinical Trials Browser

Phase 1 × Solid Tumor, Adult × pembrolizumab × Clear all

NCT05763004 2024-10-08

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06462794 2024-09-19

First In Human Study of CX-801 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult